North Dakota HB 1032: Relating to prescription drug cost transparency; to provide a continuing appropriation; and to provide a penalty.

Status: Filed with Secretary Of State 04/28 (as of 2021-04-29)

State: North Dakota · Session: 67 · Bill: HB 1032

Sponsors: Legislative Management

View North Dakota HB 1032 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.